Welcome to LookChem.com Sign In|Join Free
  • or
Carbamic acid, (3-oxo-4-isoxazolidinyl)-, 1,1-dimethylethyl ester (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

359004-20-9

Post Buying Request

359004-20-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

359004-20-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 359004-20-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,0,0 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 359004-20:
(8*3)+(7*5)+(6*9)+(5*0)+(4*0)+(3*4)+(2*2)+(1*0)=129
129 % 10 = 9
So 359004-20-9 is a valid CAS Registry Number.

359004-20-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (3-oxo-isoxazolidin-4-yl)-carbamic acid tert-butyl ester

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:359004-20-9 SDS

359004-20-9Downstream Products

359004-20-9Relevant academic research and scientific papers

ANTHRANILAMIDES, THEIR USE AS INSECTICIDE AND PROCESSES FOR PREPARING THE SAME.

-

Page/Page column 69, (2019/07/13)

The present invention provides novel anthranilamides of Formula I, wherein, the definition of W1, W2, D, Z1, E, R1, R2, R3, R4, m is as described in the description. The present

Kinase inhibitor compounds

-

Page/Page column 43, (2009/04/24)

The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 359004-20-9